Results per Page:
Oncology Insights with Dr. Petros Grivas - Episode 3
Dr. Rachael Safyan gets to Meet the Greek
Oncology Insights with Dr. Petros Grivas - Episode 2
Dr. Cristina Rodriguez gets to Meet the Greek
Oncology Insights with Dr. Petros Grivas - Episode 1
Meet the Greek: A New Podcast on Cancer Care and Research
AI technology is making charting less time-consuming
Fred Hutch and UW are part of a pilot program testing Abridge ‘ambient listening’ tool
Fred Hutch is one of the only centers in the region offering oral medicine services
Specialized oral care for cancer patients is part of multidisciplinary care
New horizons in infectious disease treatment and prevention in immunocompromised patients
The 5th Symposium on Infectious Disease in the Immunocompromised Host emphasized new opportunities, next generation
New hope for people with colorectal cancer that has spread to the liver
Fred Hutch is the only center in Washington state offering high-dose chemotherapy through hepatic artery infusion
Multiple myeloma is treatable, not curable. Is that set to change?
Some experts believe a ‘functional cure’ is already within reach
Fred Hutch deploys AI technology to help analyze colonoscopies
GI Genius flags suspicious findings with a green square
50 years of doing hard things
Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
What’s new in breast cancer research? SABCS24 looks at ctDNA, AI and ‘right-sizing’ treatment
Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices
Taking a frothy risk to advance gene therapy
Fred Hutch scientists hope foam could be a cost-reducing, access-enhancing vehicle for delivering future gene therapies
Comprehensive Hematology and Oncology Review Course marks 15 years
Started as a personal project, oncology course now covers hematology, too
Breast cancer screening guidelines change — again
U.S. Preventive Services Task Force recommends mammograms every other year for those at average risk, starting at age 40
Bacteria subtype linked to growth in up to 50% of human colorectal cancers, Fred Hutch researchers report
A study published in Nature suggests that a subtype of Fusobacterium nucleatum underlies colorectal cancer growth in humans and could be useful in screening and treatments
Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer
The New England Journal of Medicine published findings of a blood test for detecting circulating tumor DNA in people with average risk of colorectal cancer
New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Helps explain why only certain MCC patients respond to immune checkpoint inhibitors, could point toward new strategies to improve treatment responses
Immune cells vs. metastasis: ‘It’s a numbers game’
Fred Hutch scientists prevent metastasis by boosting cancer-killing T cells in patients
Reducing frequency of immunotherapy dosing could save money and time, keep patients on therapy longer
Study of immune checkpoint inhibitor dosing in patients with advanced skin cancers could help guide long-term treatment plans